건강 보도자료
-
- DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP
- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the ...
- 06월 29일 09:34
-
- Burjeel Holdings Prices First MENA Healthcare Sukuk Since 2018, 3.2x Oversubscribed
- The offering attracted significant demand from high-quality international and regional investors, with the orderbook peaking at USD 1.6 billion, representing 3.2x oversubscription. The strength of the orderbook enabled Burjeel to tighten pricing f...
- 06월 28일 14:55
